By Babatunde Jose
Today’s sermon touches on a very sad development which tends to verge on the spiritually disturbing. According to my friend Tatalo Alamu of Gbogan, it is a morbid oncology at its most classic and benumbing.
We all know that death comes with different attendant issues; short or prolonged illness, accident, both domestic or external including plane crash or automobile, altercation with spirits or even church leaders, not to talk of curse from Isese adherents. Sometimes, death comes visiting in the early hours of the morning when we are not fully awake to acknowledge its presence or late at night when we have entered the twilight zone.
Our people regard death as a debt we all owe our Creator. My friend’s mother said: *Gbese niku Baba Moradeun, ko se niti o nisan. Aiye o nipekun o ba je nje die ki nto ma lo:* Death is an obligatory debt that every living person must pay. Life is an endless feast. Let me just take my own bite before I am recalled.
Death is no respecter of gender, age or definition. It takes the child and leaves the parents, it takes the Taiwo and leaves the Kehinde, it takes the mother and leaves the new born, it takes the strong and leaves the weakling.
Our Quran says in *Surah Al Imran, 3:185: Every soul will taste death, and you will only be given your [full] compensation on the Day of Resurrection. So he who is drawn away from the Fire and admitted to Paradise has attained [his desire]. And what is the life of this world except the enjoyment of delusion.*
There are so many diseases that lead to death. The most common is cancer. However, there are many variants of cancer, one of which is Cancer of the Pancreas.
What follows is a prima on pancreatic cancer; a malignant disease where abnormal cells grow uncontrollably in the pancreas, often diagnosed at an advanced stage due to minimal early symptoms.
Pancreatic cancer occurs when abnormal cells in the pancreas grow uncontrollably, affecting either the cells which produce digestive enzymes or endocrine cells (which produce hormones like insulin). About 70% of pancreatic cancers develop in the head of the pancreas, with exocrine tumors, particularly adenocarcinomas: Adenocarcinomas are a type of cancer that can affect various organs, including the lungs, stomach, pancreas, and colon. Adenocarcinomas are the most common form of breast cancer and account for a significant percentage of other cancers, such as 99% of prostate cancers and 85% of pancreatic cancers.
Several factors can increase the risk of pancreatic cancer, including age (average diagnosis at 72 years), smoking, obesity, family history, genetic mutations, diabetes, and excessive alcohol consumption. Inherited genetic mutations account for approximately 5–10% of cases – Cancer Council.
Early-stage pancreatic cancer often causes no symptoms, making early detection difficult. When symptoms appear, they may include: Jaundice (yellowing of the skin and eyes, dark urine); unexplained weight loss; abdominal or back pain; new-onset diabetes (10–20% of cases); digestive issues such as nausea or loss of appetite.
According to the Cancer Council, diagnosis typically involves a combination of blood tests, imaging scans (ultrasound, CT, MRI, PET), and tissue sampling (biopsy via fine-needle aspiration, endoscopy, or laparoscopy) to confirm the presence and stage of cancer. Genetic testing may also be performed to identify inherited mutations.
According to MedicineNet, Pancreatic cancer is often diagnosed at a late stage, which contributes to its high lethality. Survival rates vary by stage.
The only potentially curative treatment is surgical removal of the tumor, sometimes involving partial or total removal of the pancreas. Additional treatments include: Chemotherapy, Radiation therapy, Targeted therapies for specific genetic mutations and Supportive care to manage symptoms and improve quality of life.
Ongoing research focuses on genetic mapping, targeted therapies, and early detection methods to improve outcomes. Support is available through cancer organizations, providing guidance for patients and families coping with the disease.
Pancreatic cancer remains challenging due to its rapid progression and aggressive metastasis.
Life expectancy for pancreatic cancer varies widely by stage, ranging from several years for early-stage tumors to only a few months for advanced stage 4 disease.
Johns Hopkins Medicine says the overall five-year survival rate for pancreatic cancer is approximately 12–12.5 percent, reflecting the fact that most cases are diagnosed at advanced stages when treatment is more difficult. Early detection significantly improves outcomes, but pancreatic cancer often shows few symptoms until it has metastasized.
Factors affecting prognosis include Tumor resectability: Resectable pancreatic cancer refers to tumors that can be completely removed through surgery, typically when they are confined to the pancreas and have not invaded nearby blood vessels.
The term resectable indicates that the pancreatic tumor can be surgically removed. It is usually diagnosed in the early stages when the cancer is localized and has not spread significantly.
Resectability could be borderline when the cancer may have spread to nearby blood vessels but is still considered potentially removable after treatment, such as chemotherapy or radiation, to shrink the tumor.
In contrast, unresectable pancreatic cancer cannot be completely removed due to extensive spread to surrounding tissues or distant organs.
The primary treatment for resectable pancreatic cancer is surgical intervention. The type of surgery depends on the tumor’s location within the pancreas.
According to the American Cancer Society, the prognosis for patients with resectable pancreatic cancer is generally better than for those with unresectable disease, as complete surgical removal of the tumor can lead to improved survival rates. However, the overall outcome depends on various factors, including the tumor’s size, location, and the patient’s overall health.
In conclusion, resectable pancreatic cancer is a critical classification that allows for surgical intervention, which is the most effective treatment option available. Early detection and appropriate treatment planning are essential for improving patient outcomes.
Patients diagnosed before metastasis may become disease-free in up to 10 percent of cases.
Pancreatic neuroendocrine tumors (PNETs) have a better prognosis, with a five-year survival rate of 54 percent for certain subtypes, compared to the more common pancreatic adenocarcinomas.
Access to high-volume centers and multidisciplinary care can improve outcomes through advanced surgical techniques and personalized therapy.
Pancreatic cancer prognosis is highly dependent on stage at diagnosis. Early-stage, resectable tumors offer the best chance for longer survival. Advanced-stage pancreatic cancer has a very limited life expectancy, emphasizing the importance of early detection and specialized care.
The onset of advanced stage pancreatic cancer is what happened to our friend, Alhaji Moshood Olatunde Bello 1951-2026, whose health took a rapid deterioration after he was diagnosed with advanced, metastasized pancreatic cancer. He gave up the fight on the night of Monday 6th April and being a Muslim and an Alfa, was buried on Tuesday 7th April at Ijebu Ode, where he hailed from. Inna lillahi wa ina ilehi rajiun.
Latunde, as friends used to call him, came from a deeply religious Islamic home and was deeply religious until he fell into the satanic trap of happy-go-lucky friends after his university years. A graduate of pharmacy at Great Ife, Latunde attended Adeola Odutola College and Muslim College (Museduco) both in Ijebu Ode. He was a quiet and studious fellow; hence, I did not know him at Museduco Varsity, where I did my higher school in Ijebu Ode. His life took a trajectory for the speed lane after our friend served with Dele Fajemirokun and his gang in Jos.
Latunde and another friend will later team up with Dele in their various business deals, leading to Latunde forming Mobell Trading Company, which grew into a major paper importer.
After retirement, Latunde lived a quiet life in his sprawling home in VGC. Like all of us, he has had his taste of health challenges, one of which culminated in his going as far as India for a prostate operation. Since then he had been pissing well and reduced his drinking to the less harmful H2O. But, no matter how we take precaution, death will always find a cause. It was his time to go and meet his Maker.
I understand there is always a welcoming party in the beyond where discussions center around the state of things here on earth. He would have met other departed friends like Akin Fasakin, Dele Adeola, Goke Omisore, Femi Adegoke, Tunde Dawodu, and others too numerous to name here.
Unfortunately, he would not have glowing stories to tell. These are not the best of times down here. War everywhere, kidnappings, terrorism and all forms of insecurity and Trump messing around, there is nothing good to relate to the people up there.
May the Almighty Lord forgive all his sins and shortcomings and may the Lord comfort his loved ones, grant them the fortitude to bear the irreplaceable loss. We pray that Allah in His compassion will grant Olatunde Bello, Jannatul Firdous, and preserve those he left behind – his wife and children and we his friends and compatriots. Inna lillahi wa ina ilehi rajiun.
Until we meet in the Resurrection, Latunde, sun re oo!
Barka Juma’at and a happy weekend
